High-dose oral medroxyprogesterone acetate or tamoxifen as adjuvant hormone therapy for node-negative early-stage breast cancer: randomized trial with 7-year update (Q44268463)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose oral medroxyprogesterone acetate or tamoxifen as adjuvant hormone therapy for node-negative early-stage breast cancer: randomized trial with 7-year update |
scientific article |
Statements
1 reference
High-dose oral medroxyprogesterone acetate or tamoxifen as adjuvant hormone therapy for node-negative early-stage breast cancer: randomized trial with 7-year update (English)
1 reference
Christian Focan
1 reference
Marc Beauduin
1 reference
Francoise Majois
1 reference
Jean-Luc Canon
1 reference
Giuseppe Cusumano
1 reference
Danielle Focan-Henrard
1 reference
Jean-Pierre Lobelle
1 reference
Adjuvant Breast Cancer Project, Belgium
1 reference
1 June 2004
1 reference
1 reference
5
1 reference
2
1 reference
136-141
1 reference
Identifiers
1 reference
1 reference